ORGANOGENESIS HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.11 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-07
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.11M shares, a 29.07% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 82.54K shares.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.64M shares, a 37.85% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.64M shares, a 25.71% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 3.55M shares, a 150.63% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.42M shares, a 32.59% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-03-31 | 1.11M shares 10-Q · filed 2026-05-07 | 1.19M shares derived: sum of 2 quarters · filed 2026-05-07 | 1.19M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.19M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 82.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 82.54K shares derived: sum of 2 quarters · filed 2026-02-26 | 82.54K shares derived: sum of 3 quarters · filed 2026-02-26 | 1.64M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-06 | 1.56M shares 10-Q · filed 2025-11-06 | 1.56M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.56M shares 10-Q · filed 2025-08-07 | 1.56M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.56M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-03-31 | 1.56M shares 10-Q · filed 2026-05-07 | 1.56M shares derived: sum of 2 quarters · filed 2026-05-07 | 1.56M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.56M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 2.64M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-06 | 2.64M shares 10-Q · filed 2025-11-06 | 2.64M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 2.64M shares 10-Q · filed 2025-08-07 | 2.64M shares derived: sum of 3 quarters · filed 2025-08-07 | 2.64M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 2.64M shares 10-Q · filed 2025-05-08 | 2.64M shares derived: sum of 2 quarters · filed 2025-05-08 | 2.64M shares derived: sum of 3 quarters · filed 2025-05-08 | 2.64M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-27 | 0.00 shares derived: sum of 3 quarters · filed 2025-02-27 | 3.55M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-12 | 3.55M shares 10-Q · filed 2024-11-12 | 3.55M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 3.55M shares 10-Q · filed 2024-08-08 | 3.55M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.55M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 3.55M shares 10-Q · filed 2024-05-09 | 3.55M shares derived: sum of 2 quarters · filed 2024-05-09 | 3.55M shares derived: sum of 3 quarters · filed 2024-05-09 | 3.55M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-29 | 0.00 shares derived: sum of 3 quarters · filed 2024-02-29 | 1.42M shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 1.42M shares 10-Q · filed 2023-11-09 | 1.42M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.42M shares 10-Q · filed 2023-08-09 | 1.42M shares derived: sum of 3 quarters · filed 2023-08-09 | 1.45M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 1.42M shares 10-Q · filed 2023-05-10 | 1.42M shares derived: sum of 2 quarters · filed 2023-05-10 | 1.45M shares derived: sum of 3 quarters · filed 2023-05-10 | 1.45M shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 32.56K shares derived: sum of 2 quarters · filed 2023-03-01 | 32.56K shares derived: sum of 3 quarters · filed 2023-03-01 | 1.07M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 32.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 32.56K shares derived: sum of 2 quarters · filed 2022-11-09 | 1.07M shares 10-Q · filed 2022-11-09 | 1.07M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.04M shares 10-Q · filed 2022-08-09 | 1.04M shares derived: sum of 3 quarters · filed 2022-08-09 | 1.05M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 1.04M shares 10-Q · filed 2022-05-10 | 1.04M shares derived: sum of 2 quarters · filed 2022-05-10 | 1.05M shares derived: sum of 3 quarters · filed 2022-05-10 | 2.59M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 15.00K shares derived: sum of 2 quarters · filed 2022-03-01 | 1.55M shares derived: sum of 3 quarters · filed 2022-03-01 | 1.55M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 1.55M shares derived: sum of 2 quarters · filed 2021-11-09 | 1.55M shares 10-Q · filed 2021-11-09 | 1.55M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | 1.54M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.54M shares 10-Q · filed 2021-08-09 | 1.54M shares derived: sum of 3 quarters · filed 2021-08-09 | 1.54M shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-16 | 100.00K shares 10-K · filed 2021-03-16 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 100.00K shares 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | 100.00K shares 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | 170.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 170.46K shares derived: sum of 2 quarters · filed 2020-03-09 | 248.57K shares 10-K · filed 2020-03-09 | |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 78.11K shares 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | 78.11K shares 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |